Serving leading biopharmaceutical companies globally:

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Ramucirumab - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for ramucirumab

Tradenames:	1
Patents:	34
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for ramucirumab

Recent Clinical Trials for ramucirumab

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Merck Sharp & Dohme Corp.	Phase 2
Masahiro Tsuboi	Phase 2
Mayo Clinic	Phase 2

See all ramucirumab clinical trials

Pharmacology for ramucirumab

Mechanism of Action	VEGFR2 Inhibitors

Patent Text Search: US Patents for ramucirumab

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Eli Lilly And Co	CYRAMZA	ramucirumab	INJECTABLE;INJECTION	125477	001	2014-04-21	Start Trial	PTC Therapeutics, Inc. (South Planfield, NJ)	2024-03-15	RX		search
Eli Lilly And Co	CYRAMZA	ramucirumab	INJECTABLE;INJECTION	125477	001	2014-04-21	Start Trial	PTC Therapeutics, Inc. (South Plainfield, NJ)	2025-03-15	RX		search
Eli Lilly And Co	CYRAMZA	ramucirumab	INJECTABLE;INJECTION	125477	001	2014-04-21	Start Trial	biOasis Technologies, Inc. (Vancouver, British Columbia, unknown)	2031-08-05	RX		search
Eli Lilly And Co	CYRAMZA	ramucirumab	INJECTABLE;INJECTION	125477	001	2014-04-21	Start Trial	biOasis Technologies, Inc. (Richmond, CA)	2033-03-13	RX		search
Eli Lilly And Co	CYRAMZA	ramucirumab	INJECTABLE;INJECTION	125477	001	2014-04-21	Start Trial	SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR)	2033-05-29	RX		search
Eli Lilly And Co	CYRAMZA	ramucirumab	INJECTABLE;INJECTION	125477	001	2014-04-21	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for ramucirumab

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
European Patent Office	3160499	Start Trial
European Patent Office	2200657	Start Trial
Israel	169769	Start Trial
European Patent Office	2526421	Start Trial
European Patent Office	2396036	Start Trial
China	107735090	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Dow

Boehringer Ingelheim

Baxter

Medtronic

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.